Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 18Sanofi
Reset all filters
01 6Injectable Solution
02 2Injection fluid, resolution
03 1Lixisenatide 10Mcg 3Ml 1 Units Parenteral Use
04 1Lixisenatide 10Mcg+20Mcg 3Ml 1+1 Units Parenteral Use
05 1Lixisenatide 20Mcg 3Ml 2 Units Parenteral Use
06 1SOLUTION
07 3SOLUTION;SUBCUTANEOUS
08 2Solution For Injection
09 1Blank
Reset all filters
01 2Allowed
02 2Approved
03 4Authorized
04 1Prescription
05 9Blank
Reset all filters
01 2ADLYXIN
02 7Lyxumia
03 1Lyxumia Boot Gasket
04 1SOLIQUA
05 1SOLIQUA 100/33
06 6Suliqua
Reset all filters
01 1Canada
02 3Italy
03 3Norway
04 4Spain
05 2Sweden
06 2Switzerland
07 3USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : ADLYXIN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.15MG/3ML (0.05MG/ML)
Packaging :
Approval Date :
Application Number : 208471
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
Brand Name : ADLYXIN
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 0.3MG/3ML (0.1MG/ML)
Packaging :
Approval Date :
Application Number : 208471
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : USA
INSULIN GLARGINE; LIXISENATIDE
Brand Name : SOLIQUA 100/33
Dosage Form : SOLUTION;SUBCUTANEOUS
Dosage Strength : 300 UNITS/3ML;99MCG/3ML (100 UNITS/ML;33MCG/ML)
Packaging :
Approval Date :
Application Number : 208673
Regulatory Info :
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 10Mcg 3Ml 1 Units Parenteral Use
Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 20Mcg 3Ml 2 Units Parenteral Use
Dosage Strength : 2 cartridges SC in preriemp pen 3 ml 20 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Lyxumia
Dosage Form : Lixisenatide 10Mcg+20Mcg 3Ml 1+1 Units Parenteral Use
Dosage Strength : 1 cartridge SC in preriemp pen 3 ml 10 mcg + 1 cartridge SC in preriemp pen 3 ml 20 mcg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Lyxumia
Dosage Form : Injection fluid, resolution
Dosage Strength : 10 mcg
Packaging : Finish filled pen
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Lyxumia
Dosage Form : Injection fluid, resolution
Dosage Strength : 20 mcg
Packaging : Finish filled pen
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Lyxumia Boot Gasket
Dosage Form :
Dosage Strength :
Packaging : Finish filled pen
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100mg;50mg
Packaging :
Approval Date : 05/10/2017
Application Number : 66283
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100mg;33mg
Packaging :
Approval Date : 05/10/2017
Application Number : 66283
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Solution For Injection
Dosage Strength : 100IU/ml;33mcg/ml
Packaging :
Approval Date : 11/01/2017
Application Number : 20160309000010
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Approved
Registration Country : Sweden
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Solution For Injection
Dosage Strength : 100IU/ml;50mcg/ml
Packaging :
Approval Date : 11/01/2017
Application Number : 20160309000027
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SOLIQUA
Dosage Form : SOLUTION
Dosage Strength : 33MCG/ML
Packaging :
Approval Date :
Application Number : 2478293
Regulatory Info : Prescription
Registration Country : Canada
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100UNIT; 33 MCG
Packaging :
Approval Date : 2017-02-03
Application Number : 1161157004
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Insulin Glargine; Lixisenatide
Brand Name : Suliqua
Dosage Form : Injectable Solution
Dosage Strength : 100UNIT; 50MCG
Packaging :
Approval Date : 2017-02-03
Application Number : 1161157002
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Lyxumia
Dosage Form : Injectable Solution
Dosage Strength : 10MCG
Packaging :
Approval Date : 2013-02-13
Application Number : 12811001
Regulatory Info : Authorized
Registration Country : Spain
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Lyxumia
Dosage Form : Injectable Solution
Dosage Strength : 20MCG
Packaging :
Approval Date : 2013-02-13
Application Number : 12811003
Regulatory Info : Authorized
Registration Country : Spain